Aleta Biotherapeutics
Natick, US · Delaware corporation
Founders & leadership
ML
Mark LeuchtenbergerExecutive Chairman of the Issuer
Reported raises · per SEC filings
Form D private placements$13.7M disclosed across 1 round · 2021
▶$13.7MraisedJul 2021 · 6 investors · BiotechnologyRule 506(b)
▶$13.7MraisedJul 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark LeuchtenbergerExecutive Officer
- Amount sold
- $13.7M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aleta Biotherapeutics raised?
- Aleta Biotherapeutics has disclosed $13.7M raised across 1 round.
- Where is Aleta Biotherapeutics headquartered?
- Aleta Biotherapeutics is headquartered in Natick, US.